dalcetrapib

Roche’s Good Cholesterol Drug Shows Negative Side Effects

Roche’s Good Cholesterol Drug Shows Negative Side Effects

Bloomberg

Roche's Pain May Be Merck's Gain

Roche's Pain May Be Merck's Gain

Seeking Alpha

Roche Drops After Halting Cholesterol Drug Development

Roche Drops After Halting Cholesterol Drug Development

Bloomberg

Pushing Onwards With CETP Inhibition: What Big-Time Drug Development Is All About

Pushing Onwards With CETP Inhibition: What Big-Time Drug Development Is All About

Seeking Alpha

Roche expects $10 billion sales for HDL drug

Roche expects $10 billion sales for HDL drug

Yahoo/Reuters

Roche Rises After Good-Cholesterol Drug Shows Promise in Study

Roche Rises After Good-Cholesterol Drug Shows Promise in Study

Bloomberg

Roche Seeks Win on Heart Pill Where Pfizer Failed

Roche Seeks Win on Heart Pill Where Pfizer Failed

Bloomberg